Results 131 to 140 of about 321,344 (208)
Real-world experience with belimumab in lupus nephritis: insights from the Spanish cohort. [PDF]
Front ImmunolHuerta A, López-Sánchez P, Martínez E, Quintana LF, Martín-Gómez A, Lopes V, Rabasco C, Rodriguez JA, Rodriguez C, Temprado A, Lopez-Mendoza M, Borrego FJ, Afonso S, Rodriguez A, Fernandez L, Gago M, Prados MDC, Gracia O, Sierra M, Sánchez-Agesta M, Carbayo J, Hadad F, Romera A, Cox R, Mora JM, Rivas B, Fernandez-Solis J, Gomez-Preciado F, Mora MT, Marquez E, Espino M, Larramendi C, Lopez-Corbeto M, Devolder-Nicolau A, Puente-Garcia A, Shabaka A, Gonzalez S, Martin C, Mon C, Tato A, Villa D, Galindo M, Martin-Testillano L, Portolés J, Morales E. +44 moreeuropepmc +1 more sourceEarly laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study. [PDF]
BMC NephrolYadigar S, Akgür S, Arslan F, Sezen M, Özcan B, Ayaz EY, Doğantekin B, Atay İ, Değer SM, Demir M, Koyuncu S, Yılmaz Ü, İnci A, Çolak H, Demirelli B, Tuğlular S, Oğuz EG, Aylı MD, Avanaz E, Yılmaz F, Doğan B, Karaköse S, Karakan MŞ, Gürlek B, Türkmen K, Baloğlu İ, Batmazoğlu M, Mert M, Aydın E, Aydın FY, Parmaksız E, Özdemir P, Ediz B, Aydın Z, Demir ME, Sezer S, Ünver S, Baykal Ö, Çakmak BA, Altuntaş A, İslam M, Koçak Yücel FS, Mert M, Dursun B, Eren N, Bardak Demir S, Güven AT, Bilgiç MA, Erdut A, Keskin G, Şahin AZ, Horoz M, Tekinyıldız M, Durunay M, Yalın SF, Altunok M, Sarı F, Sarı R, Torun D, Kahvecioğlu S, Yalçınkaya AS, Akagün T, Çelik H, Kazan S, Öztürk İ, Polat M, Aydın MF, Meşe M, Yavuz Umut MH, Demirezen A, Derici Ü, Altun E, Bakırdöğen S, Kara E, Akgöl C, Aykent MB, İlter A, Ekmekçi A, Ulu S, Özlüer Başer B, Arıcı M, Bakır EA, Şengül E. +82 moreeuropepmc +1 more sourceTarget Weight Optimization based on a Modified VExUS Protocol in Hemodialysis: The VexHD Prospective Multi-Center Study.
Cardiorenal MedMuñoz Ramos P, Ortiz A, Sanz AB, Giorgi M, Ruiz López-Alvarado P, Oñate I, Mercado VR, de La Flor Merino JC, Vaca Gallardo M, León-Machado ML, López de la Manzanara V, Manouchehri M, Santos Alonso C, Carrasco S, Navas Jiménez MÁ, de Sequera P, Quiroga B. +16 moreeuropepmc +1 more sourceRetraction Note: Increased WNT10B/FOXO6 signaling promotes cell fate transition in renal tubular cells to aggravate renal inflammation and fibrosis. [PDF]
Nat CommunMiao J, Li J, Meng P, Li X, Huang J, Liang Y, Ling X, Wang X, Shen W, Zhou S, Peng H, Zhang Y, Liu Y, Hou FF, Zhou L. +14 moreeuropepmc +1 more sourceA Randomized Controlled Trial of Two Corticosteroid Dosages for Relapsed Childhood Steroid-Sensitive Nephrotic Syndrome: The OPtimising dosE in Nephrotic Syndrome (OPEN) Trial Protocol. [PDF]
Kidney Int RepLarkins NG, McCarthy H, Carter SA, Kim S, Francis A, Kermond R, Johnstone L, Prestidge C, Cook W, Sheriff D, Mallitt KA, Viecelli AK, Teng X, Guha C, Christian M, Samuel S, Loffler K, Saikia R, Howell M, Wong G, Jaure A, Teixeira-Pinto A, Craig JC. +22 moreeuropepmc +1 more source